Skip to main content
Equibles
EXEL logo

EXEL · Exelixis, Inc. · Metrics

Track EXEL — free

Use EXEL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EXEL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$64.70 +0.31 (+0.48%)
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$15.95B
Shares
247.78M
Volume · Oct 21 902.45K Avg daily vol (3M) 2.37M

EXEL metrics

96 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$64.39
Market cap
$15.95B

Price action

20 metrics
Price change (1W)
+8.2%
Price change (30D)
+12.5%
Price change (3M)
+14.7%
Price change (6M)
+40.3%
Price change (YTD)
+46.9%
Price change (1Y)
+86.4%
Trailing year
Price change (5Y)
+197.6%
52-week high
$64.39
52-week low
$34.54
Change from 52-week high
+0.0%
Change from 52-week low
+86.4%
Annualized volatility
34.6%
Annualized volatility (3M)
33.7%
Beta
0.7
RSI (14D)
74.2
Price vs SMA 50
+12.6%
Price vs SMA 200
+28.7%
Avg volume (3M)
2.37M
Relative volume
0.9
Average dollar volume
$133.95M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
247.78M

Valuation

12 metrics
P / E (TTM)
20.2
Trailing earnings · reciprocal yield 5.0%
PEG ratio
0.8
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
6.5×
reciprocal yield 15.3%
P / book
8.7
reciprocal yield 11.6%
FCF yield
7.3%
TTM · current market cap
Buyback yield
7.0%
P / FCF
13.6
reciprocal yield 7.3%
P / operating cash flow
13.5
reciprocal yield 7.4%
Earnings yield
5.4%

Historical valuation

8 metrics
P / E historical average (3Y)
25.6×
reciprocal yield 3.9%
P / E historical average (5Y)
29.1×
reciprocal yield 3.4%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
7.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-29
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
96.4%
Operating margin
39.9%
Trailing 12 months
Net margin
35.3%
Gross profit (TTM)
$705.28M
Operating profit (TTM)
$971.51M
Net income (TTM)
$860.62M
Trailing 12 months
Diluted EPS (TTM)
$3.19
FCF margin
48.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$9.02
Gross profit per diluted share (TTM)
$2.22
Operating profit per diluted share (TTM)
$3.60
EBITDA per diluted share (TTM)
$3.70
Net income per diluted share (TTM)
$3.18
Operating cash flow per diluted share (TTM)
$4.38
Free cash flow per diluted share (TTM)
$4.33
Capital expenditures per diluted share (TTM)
$0.04
R&D per diluted share (TTM)
$3.05
Stock compensation per diluted share (TTM)
$0.42
Book value per share
$8.23

Growth

11 metrics
Revenue growth YoY
+10.6%
Year over year
Net income growth YoY
+14.7%
Revenue (TTM)
$2.44B
Trailing 12 months
EPS growth YoY
+26.2%
Shares change YoY
-8.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+12.9%
Revenue CAGR (5Y)
+18.6%
EPS CAGR (3Y)
+70.6%
EPS CAGR (5Y)
+51.4%
FCF CAGR (3Y)
+37.8%
FCF CAGR (5Y)
+37.4%

Quality

14 metrics
Return on equity
46.7%
Return on assets
34.5%
Debt / equity
—
Current ratio
3.5
EBITDA (TTM)
$999.81M
Free cash flow (TTM)
$1.17B
Quick ratio
3.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$281.45M
Total assets
$2.49B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.18B
Capital expenditures (TTM)
$10.96M
R&D (TTM)
$824.32M
SG&A (TTM)
$533.92M
Stock compensation (TTM)
$112.59M
R&D / revenue
33.8%
Stock compensation / revenue
4.6%

Ownership (13F)

9 metrics
13F filers
765
13F filer change QoQ
+58
Institutional ownership
105.2%
Conviction holders (share of 13F filers)
1.3%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+0.2%
Holder tenure
17.7
Price vs estimated holder cost
+52.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
24.6%

Short interest

3 metrics
Short interest
11.4%
Latest settlement · 12.7 days to cover
Days to cover
12.7d
Short-squeeze score
76 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$526,512
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 939767 CUSIP 30161Q104 13F (30d) 125 filings 121 filers Visit website Investor relations